Lisa S. Williams

1.1k total citations
10 papers, 728 citations indexed

About

Lisa S. Williams is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisa S. Williams has authored 10 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisa S. Williams's work include HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Heavy Metals in Plants (3 papers). Lisa S. Williams is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Heavy Metals in Plants (3 papers). Lisa S. Williams collaborates with scholars based in United States, United Kingdom and Denmark. Lisa S. Williams's co-authors include Michael F. Press, Richard S. Finn, María Koehler, Cristina Oliva, Michael Arbushites, Judy Dering, Angelo Di Leo, Zeba Aziz, José Bines and Zanete Zvirbule and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and The Lancet Oncology.

In The Last Decade

Lisa S. Williams

10 papers receiving 712 citations

Peers

Countries citing papers authored by Lisa S. Williams

Since Specialization

Citations

This map shows the geographic impact of Lisa S. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa S. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa S. Williams more than expected).

Fields of papers citing papers by Lisa S. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa S. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa S. Williams. The network helps show where Lisa S. Williams may publish in the future.

Co-authorship network of co-authors of Lisa S. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa S. Williams. A scholar is included among the top collaborators of Lisa S. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa S. Williams. Lisa S. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE 2020 ·Journal of Clinical Oncology ·Stephen Johnston, Roberto Hegg, Seock‐Ah Im, In Hae Park, Olga Burdaeva, G. Kurteva, Michael F. Press, Sergei Tjulandin, Hiroji Iwata, Sérgio D. Simon, Sarah Kenny, Séverine Sarp, Miguel Izquierdo, Lisa S. Williams, William J. Gradishar	82
2	Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer 2015 ·European Journal of Cancer ·Frances Boyle, Ian E. Smith, Joyce O’Shaughnessy, Bent Ejlertsen, Aman U. Buzdar, P. Fumoleau, William J. Gradishar, Miguel Martín, Beverly Moy, Martine Piccart, Kathleen I. Pritchard, (unknown), Mayur M. Amonkar, Yingjie Huang, Erica Rappold, Lisa S. Williams, (unknown), Tomomi Kaneko, Dianne M. Finkelstein, Paul E. Goss	8
3	HLA-DRB107:01 biomarker characterization of hepatotoxicity during lapatinib combination therapies in ALTTO. 2015 ·Journal of Clinical Oncology* ·Colin F. Spraggs, (unknown), Liling Warren, Lisa S. Williams, Linda P. Briley, Dana J. Fraser, (unknown), Zeba Aziz, Zhongsheng Tong, (unknown), Ajay Mehta, Nicola Jackson, Julie Byrne, Michael Andersson, Masakazu Toi, Lyndsay N. Harris, Julie R. Gralow, Rocco J. Crescenzo, Alison Armour	1
4	Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial 2012 ·The Lancet Oncology ·Paul E. Goss, Ian E. Smith, Joyce O’Shaughnessy, Bent Ejlertsen, Manfred Kaufmann, Frances Boyle, Aman U. Buzdar, P. Fumoleau, William J. Gradishar, Miguel Martín, Beverly Moy, Martine Piccart, Kathleen I. Pritchard, Deborah Lindquist, Yanin Chávarri-Guerra, Gursel Aktan, Erica Rappold, Lisa S. Williams, Dianne M. Finkelstein	100
5	Adjuvant lapatinib in women with early-stage HER2-positive breast cancer (HER2+ BC): Analysis of the hormone receptor-negative subgroup of the intent-to-treat (ITT) population of the TEACH trial. 2012 ·Journal of Clinical Oncology ·Ian E. Smith, Dianne M. Finkelstein, Joyce O’Shaughnessy, Beverly Moy, Bent Ejlertsen, Manfred Kaufmann, Aman U. Buzdar, P. Fumoleau, William J. Gradishar, Miguel Martín, Frances Boyle, Martine Piccart, Kathleen I. Pritchard, Deborah Lindquist, Erica Rappold, Lisa S. Williams, Pedro Emanuel Rubini Liedke, Yanin Chávarri-Guerra, Paul E. Goss	1
6	Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in HER2-Negative or Unknown Metastatic Breast Cancer 2009 ·Journal of Clinical Oncology ·Richard S. Finn, Michael F. Press, Judy Dering, Michael Arbushites, María Koehler, Cristina Oliva, Lisa S. Williams, Angelo Di Leo	144
7	Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer 2008 ·Journal of Clinical Oncology ·Angelo Di Leo, Henry Gómez, Zeba Aziz, Zanete Zvirbule, José Bines, Michael Arbushites, (unknown), María Koehler, Cristina Oliva, Steven H. Stein, Lisa S. Williams, Judy Dering, Richard S. Finn, Michael F. Press	345
8	X-ray fluorescence measurements of Mg, P, S, CI, K, Ca, Mn, Fe, Cu, and Zn in fruits, vegetables, and grain products 1991 ·Journal of Food Composition and Analysis ·K.K. Nielson, Arthur W. Mahoney, Lisa S. Williams, V.C. Rogers	33
9	Mineral concentrations and variations in fast-food samples analyzed by x-ray fluorescence 1991 ·Journal of Agricultural and Food Chemistry ·(unknown), Arthur W. Mahoney, Lisa S. Williams, V.C. Rogers	11
10	Screening for elevated lead and tin in fruits and vegetables by Nondestructive X-ray fluorescence 1991 ·Journal of Food Composition and Analysis ·K.K. Nielson, Arthur W. Mahoney, Lisa S. Williams, V.C. Rogers	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact